These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 27521149
1. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis. Pizzi M, Gergis U, Chaviano F, Orazi A. Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149 [Abstract] [Full Text] [Related]
2. Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis. Guy A, Bidet A, Ling C, Caumont C, Boureau L, Viallard JF, Parrens M. Virchows Arch; 2021 Oct; 479(4):755-764. PubMed ID: 33934231 [Abstract] [Full Text] [Related]
3. Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis. Song MK, Park BB, Uhm JE. Int J Mol Sci; 2018 Mar 18; 19(3):. PubMed ID: 29562644 [Abstract] [Full Text] [Related]
4. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients. Wang X, Cho SY, Hu CS, Chen D, Roboz J, Hoffman R. Exp Hematol; 2015 Feb 18; 43(2):100-9.e1. PubMed ID: 25461253 [Abstract] [Full Text] [Related]
5. Fine-needle aspiration diagnosis of clonal extramedullary hematopoiesis in a case of myeloproliferative neoplasm. Shponka V, Bone K, Nomani L, Hunt B. Diagn Cytopathol; 2022 Feb 18; 50(2):E43-E46. PubMed ID: 34617678 [Abstract] [Full Text] [Related]
6. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation. Khanlari M, Wang X, Loghavi S, Wang SA, Li S, Thakral B, Bueso-Ramos CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Patel KP, Popat UR, Medeiros LJ, Konoplev S. Ann Diagn Pathol; 2022 Feb 18; 56():151860. PubMed ID: 34823075 [Abstract] [Full Text] [Related]
7. Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiology. Pizzi M, Fuligni F, Santoro L, Sabattini E, Ichino M, De Vito R, Zucchetta P, Colombatti R, Sainati L, Gamba P, Alaggio R. Hum Pathol; 2017 Feb 18; 60():95-103. PubMed ID: 27771375 [Abstract] [Full Text] [Related]
8. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. Wang X, Prakash S, Lu M, Tripodi J, Ye F, Najfeld V, Li Y, Schwartz M, Weinberg R, Roda P, Orazi A, Hoffman R. J Clin Invest; 2012 Nov 18; 122(11):3888-99. PubMed ID: 23023702 [Abstract] [Full Text] [Related]
9. Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation. Hart C, Klatt S, Barop J, Müller G, Schelker R, Holler E, Huber E, Herr W, Grassinger J. Haematologica; 2016 Nov 18; 101(11):1407-1416. PubMed ID: 27662011 [Abstract] [Full Text] [Related]
10. Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis. Miwa Y, Hayashi T, Suzuki S, Abe S, Onishi I, Kirimura S, Kitagawa M, Kurata M. Pathology; 2013 Jun 18; 45(4):408-16. PubMed ID: 23619587 [Abstract] [Full Text] [Related]
11. Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition. Prakash S, Hoffman R, Barouk S, Wang YL, Knowles DM, Orazi A. Mod Pathol; 2012 Jun 18; 25(6):815-27. PubMed ID: 22388763 [Abstract] [Full Text] [Related]
12. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly. Ito T, Akagi K, Kondo T, Kawabata H, Ichinohe T, Takaori-Kondo A. Tohoku J Exp Med; 2012 Dec 18; 228(4):295-9. PubMed ID: 23117264 [Abstract] [Full Text] [Related]
13. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis. Selicean SE, Tomuleasa C, Grewal R, Almeida-Porada G, Berindan-Neagoe I. Leuk Lymphoma; 2019 Apr 18; 60(4):876-885. PubMed ID: 30277128 [Abstract] [Full Text] [Related]
14. The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma. O'Keane JC, Wolf BC, Neiman RS. Cancer; 1989 Apr 15; 63(8):1539-43. PubMed ID: 2924261 [Abstract] [Full Text] [Related]
15. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis. Rambaldi B, Diral E, Donsante S, Di Marzo N, Mottadelli F, Cardinale L, Dander E, Isimbaldi G, Pioltelli P, Biondi A, Riminucci M, D'Amico G, Elli EM, Pievani A, Serafini M. Ann Hematol; 2021 Jan 15; 100(1):105-116. PubMed ID: 33089365 [Abstract] [Full Text] [Related]
16. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis. Leguit RJ, Broekhuizen R, de Witte M, Raymakers RAP, Goldschmeding R. Virchows Arch; 2024 May 15; 484(5):837-845. PubMed ID: 38602559 [Abstract] [Full Text] [Related]
19. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis. Kawakami T, Kimura S, Kato M, Mizoguchi M, Soma Y. J Am Acad Dermatol; 2008 Apr 15; 58(4):703-6. PubMed ID: 18342720 [Abstract] [Full Text] [Related]
20. Inability of immunomorphometric assessment of angiogenesis to distinguish primary versus secondary myelofibrosis. Sharma P, Pati HP, Mishra PC, Dinda AK, Gupta R, Sharma A, Jacob TG. Anal Quant Cytol Histol; 2011 Aug 15; 33(4):236-44. PubMed ID: 21980629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]